0001780605-22-000001.txt : 20220608 0001780605-22-000001.hdr.sgml : 20220608 20220608150925 ACCESSION NUMBER: 0001780605-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220608 DATE AS OF CHANGE: 20220608 EFFECTIVENESS DATE: 20220608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gemelli Biotech Corp. CENTRAL INDEX KEY: 0001780605 IRS NUMBER: 481304650 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-448519 FILM NUMBER: 221003331 BUSINESS ADDRESS: STREET 1: 9805 BURGEN AVE. CITY: LOS ANGELES STATE: CA ZIP: 90034 BUSINESS PHONE: (919) 451-0533 MAIL ADDRESS: STREET 1: 9805 BURGEN AVE. CITY: LOS ANGELES STATE: CA ZIP: 90034 D 1 primary_doc.xml X0708 D LIVE 0001780605 Gemelli Biotech Corp. 2020 Progress Court, Suite 100 Raleigh NC NORTH CAROLINA 27608 (919) 451-0533 DELAWARE None None Corporation true 2018 Matthew Mitcho c/o Gemelli Biotech Corp. 2020 Progress Court, Suite 100 Raleigh NC NORTH CAROLINA 27608 Executive Officer Director Mark Pimentel c/o Gemelli Biotech Corp. 2020 Progress Court, Suite 100 Raleigh NC NORTH CAROLINA 27608 Executive Officer Director James Laur c/o Gemelli Biotech Corp. 2020 Progress Court, Suite 100 Raleigh NC NORTH CAROLINA 27608 Director John A. Neczesny c/o Gemelli Biotech Corp. 2020 Progress Court, Suite 100 Raleigh NC NORTH CAROLINA 27608 Director Biotechnology Decline to Disclose 06b false 2021-12-07 false true false 0 19967887 18910941 1056946 Total amount sold includes $5,886,630.10 of cancellation of indebtedness and $13,024,311.30 of new cash. false 121 0 0 0 false Gemelli Biotech Corp. /s/ Matthew Mitcho Matthew Mitcho Chief Executive Officer 2022-06-08